Batlle E, Massagué J (2019) Transforming growth Factor-β signaling in immunity and Cancer. Immunity 50(4):924–940

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burgos M, Cavero-Redondo I, Álvarez-Bueno C, Galán-Moya EM, Pandiella A, Amir E, Ocaña A (2022) Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis. Ther Adv Med Oncol 14:17588359211072621

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Chen DT, Kurtyka C, Rawal B, Fulp WJ, Haura EB, Cress WD (2012) Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem 287(48):40106–40118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Li Q, An Y, Lv N, Xue X, Wei J, Jiang K, Wu J, Gao W, Qian Z (2013) CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Int J Oncol 43(3):877–885

Article  CAS  PubMed  Google Scholar 

Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z (2017) Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells. Onco Targets Ther 10:1503–1512

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 23(2):465–473

Article  CAS  PubMed  Google Scholar 

Fitzgerald S, Sheehan KM, O’Grady A, Kenny D, O’Kennedy R, Kay EW, Kijanka GS (2013) Relationship between epithelial and stromal TRIM 28 expression predicts survival in colorectal cancer patients. J Gastroenterol Hepatol 28(6):967–974

Article  CAS  PubMed  Google Scholar 

Hammarström S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9(2):67–81

Article  PubMed  Google Scholar 

Han Z-W, Lyv Z-W, Cui B, Wang Y-Y, Cheng J-T, Zhang Y, Cai W-Q, Zhou Y, Ma Z-W, Wang X-W, Peng X-C, Cui S-Z, Xiang Y, Yang M, Xin H-W (2020) The old CEACAMs find their new role in tumor immunotherapy. Investig New Drugs 38(6):1888–1898

Article  Google Scholar 

Hatakeyama S (2011) TRIM proteins and cancer. Nat Rev Cancer 11(11):792–804

Article  CAS  PubMed  Google Scholar 

Heinemann V, Reni M, Ychou M, Richel DJ, Macarulla T, Ducreux M (2014) Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. Cancer Treat Rev 40(1):118–128

Article  CAS  PubMed  Google Scholar 

Huang Y, Zhang SD, McCrudden C, Chan KW, Lin Y, Kwok HF (2015) The prognostic significance of PD-L1 in bladder cancer. Oncol Rep 33(6):3075–3084

Article  CAS  PubMed  Google Scholar 

Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, Brümmer J, Laffer U, Metzger U, Herrmann R (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21(19):3638–3646

Article  CAS  PubMed  Google Scholar 

Jaworska AM, Wlodarczyk NA, Mackiewicz A, Czerwinska P (2020) The role of TRIM family proteins in the regulation of cancer stem cell self-renewal. Stem Cells 38(2):165–173

Article  CAS  PubMed  Google Scholar 

Jensen-Jarolim E, Fazekas J, Singer J, Hofstetter G, Oida K, Matsuda H, Tanaka A (2015) Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer. Cancer Immunol Immunother 64(5):531–537

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson B, Mahadevan D (2015) Emerging role and targeting of Carcinoembryonic Antigen-related cell adhesion molecule 6 (CEACAM6) in human malignancies. Clin Cancer Drugs 2(2):100–111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawabata H, Azuma K, Ikeda K, Sugitani I, Kinowaki K, Fujii T, Osaki A, Saeki T, Horie-Inoue K, Inoue S (2017) TRIM44 is a poor prognostic factor for breast cancer patients as a modulator of NF-κB signaling. Int J Mol Sci 18(9):1931

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Li L, Qin J, Wu J, Dai X, Xu J (2021) OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer. Oncogene 40(1):68–84

Article  CAS  PubMed  Google Scholar 

Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R (2021) Immune Checkpoint inhibitors for the treatment of bladder Cancer. Cancers (Basel) 13(1):131.

Mishima C, Kagara N, Matsui S, Tanei T, Naoi Y, Shimoda M, Shimomura A, Shimazu K, Kim SJ, Noguchi S (2015) Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients. Springerplus 4:635

Article  PubMed  PubMed Central  Google Scholar 

Nannuru KC, Futakuchi M, Varney ML, Vincent TM, Marcusson EG, Singh RK (2010) Matrix metalloproteinase (MMP)-13 regulates mammary tumor–induced osteolysis by activating MMP9 and transforming growth factor-β signaling at the tumor-bone interface. Cancer Res 70(9):3494–3504

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poola I, Shokrani B, Bhatnagar R, DeWitty RL, Yue Q, Bonney G (2006) Expression of carcinoembryonic antigen cell adhesion molecule 6 oncoprotein in atypical ductal hyperplastic tissues is associated with the development of invasive breast cancer. Clin Cancer Res 12(15):4773–4783

Article  CAS  PubMed  Google Scholar 

Rizeq B, Zakaria Z, Ouhtit A (2018) Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. Cancer Sci 109(1):33–42

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R (2017) Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171(3):540–556 e25

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samudyata PP, Amaral PG, Engström SC, Robson ML, Nielsen T, Kouzarides G (2019) Castelo-Branco, Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. Exp Cell Res 381(1):129–138

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seki Y, Kurisaki A, Watanabe-Susaki K, Nakajima Y, Nakanishi M, Arai Y, Shiota K, Sugino H, Asashima M (2010) TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner. Proc Natl Acad Sci U S A 107(24):10926–10931

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sen B, Johnson FM (2011) Regulation of SRC family kinases in human cancers. J Signal Transduct 2011:865819

Article  PubMed  PubMed Central  Google Scholar 

Sinpitaksakul SN, Pimkhaokham A, Sanchavanakit N, Pavasant P (2008) TGF-β1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. Biochem Biophys Res Commun 371(4):713–718

Article  CAS  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  PubMed  Google Scholar 

Suzuki R, Fukui T, Kishimoto M, Miyamoto S, Takahashi Y, Takeo M, Mitsuyama T, Sakaguchi Y, Uchida K, Nishio A (2015) Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer. J Crohn’s Colitis 9(7):565–574

Article  Google Scholar 

Tanji K, Kamitani T, Mori F, Kakita A, Takahashi H, Wakabayashi K (2010) TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson’s disease and dementia with Lewy bodies. Neurobiol Dis 38(2):210–218

Article  CAS  PubMed  PubMed Central  Google Scholar 

Venuto S, Merla G, Ubiquitin Ligase E, Proteins TRIM (2019)Cell Cycle and Mitosis, Cells8(5)

Wei WS, Chen X, Guo LY, Li XD, Deng MH, Yuan GJ, He LY, Li YH, Zhang ZL, Jiang LJ, Chen RX, Ma XD, Wei S, Ma NF, Liu ZW, Luo JH, Zhou FJ, Xie D (2018) TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation. Cancer Lett 435:10–22

Article  CAS  PubMed  Google Scholar 

Wong JPC, Wei R, Lyu P, Tong OLH, Zhang SD, Wen Q, Yuen HF, El-Tanani M, Kwok HF (2017) Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer. Int J Biol Sci 13(11):1373–1386

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Q, Wong JPC, Kwok HF (2020) Putting the brakes on tumorigenesis with Natural Products of Plant Origin: insights into the Molecular Mechanisms of actions and Immune targets for bladder Cancer Treatment. Cells 9(5):1213.

Wu Q, Chen P, Li J, Lin Z, Zhang Q, Kwok HF (2023) Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: a novel strategy for drug application. Pharmacol Res 188:106654

Article  CAS  PubMed